Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML projectClaudia Sargas, Pau Montesinos, Elena Soria et al.|Haematologica|2020Cited by 37
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz et al.|Cancers|2023Cited by 30
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA groupClaudia Sargas, Rosa Ayala, María José Larráyoz et al.|Blood Cancer Journal|2023Cited by 28
Successful idiotypic vaccination following stem cell allotransplant in lymphomaAscensión López-Dı́az de Cerio, Maurizio Bendandi, Susana Inogés et al.|Leukemia & lymphoma/Leukemia and lymphoma|2012Cited by 3
Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registryEsther Prados de la Torre, Pau Montesinos, Josefina Serrano et al.|Haematologica|2024Cited by 3